Andrew Stokes promoted to Senior Director
We are delighted to announce the promotion of Andrew Stokes to Senior Director in our UK headquarters.
Andrew has 18 years of healthcare market research experience and joined Research Partnership as a graduate in 2001. Over the years he has made a significant contribution to the success of the company, both from a research perspective and in terms of providing management and leadership support.
Singapore team’s annual volunteer day
This year, volunteers from our Singapore office are collaborating with local charity, Willing Hearts.
Willing Hearts operates a soup kitchen that prepares, cooks and distributes 5,000 meals 365 days a year. Beneficiaries include the elderly, the disabled, low-income families, and migrant workers in Singapore.On 28th June, volunteers will be starting at the crack of dawn (5am!) as soon as the kitchen doors open, with everyone assigned to various stations throughout the day.
Research Partnership publishes new patient Living with Non-alcoholic Steatohepatitis (NASH) EU report
Living with Non-alcoholic Steatohepatitis (NASH) EU is a study conducted amongst 275 adults with NASH / NAFLD in France, Germany, Italy, Spain and UK. The report consists of 30-minute quantitative online and qualitative telephone interviews with patients. The report, which is now available for purchase, enables pharmaceutical companies developing products in this disease area to gain a deeper understanding of how patients come to be diagnosed with NASH, how it impacts their day-to-day lives and what their attitudes and perceptions are towards the management of their condition.
Research Partnership publishes new patient Living with Atopic Dermatitis (EU) 2019 report
Living with Atopic Dermatitis (AD) is a new quantitative study conducted amongst 403 adults living with the disease and 141 caregivers of children with AD in France, Germany, Italy, Spain and UK.
Research Partnership and Janssen awarded runner-up in the EphMRA MR Excellence Awards
We are delighted to announce that an entry submitted by Janssen and Research Partnership for the 2019 EphMRA MR Excellence Awards has been awarded runner-up in the ‘Business Impact through Innovation’ category.
The category, sponsored by Adelphi, is awarded for demonstrating innovation, which has had a real and significant business impact. The joint submission ‘Using facial analysis to uncover deeper reactions to pharmaceutical communication materials’ demonstrated how Research Partnership and Janssen used one of the latest innovations in healthcare market research, facial analysis, to gain a detailed understanding of physicians’ emotional reactions to an e-detail aid.